Knott David M Jr »

Cytokinetics shares owned by Knott David M Jr

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Knott David M Jr from 13F filings

Historical chart of Knott David M Jr investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Knott David M Jr consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Knott David M Jr

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.6M 30k 54.96
2024-03-31 $351k 5.0k 70.20

More positions owned by Knott David M Jr

Calumet Common (CLMT)
Apollo Global Management Common (APO)
Alphabet Inc-Cl C Common (GOOG)
Janus Henderson AAA CLO ETF Common (JAAA)
Darling Ingredients Common Call Option (DAR)
Xeris Biopharma Holdings Common (XERS)
Syndax Pharmaceutical Common (SNDX)
JPMorgan Chase & Co. Common (JPM)
Travere Therapeutics Common (TVTX)
Avadel Pharmaceuticals Common (AVDL)
Protagonist Therapeutics Common (PTGX)
Bridgebio Pharma Common (BBIO)
DocGo Common (DCGO)
Verona Pharma Common (VRNA)
LENZ Therapeutics Common (LENZ)

View all positions for Knott David M Jr

Top funds holding Cytokinetics

T. Rowe Price Investment Management
BlackRock
FMR
Vanguard Group
Wellington Management Company
State Street Corporation
Deep Track Capital
Geode Capital Management
Susquehanna International
Polar Capital Holdings
Rtw Investments
Goldman Sachs Group
Integral Health Asset Management
Armistice Capital
Citadel Advisors

View all funds holding Cytokinetics